Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radafaxine ER versus placebo in adults with major depressive disorder
2005-002261-37Phase 2Terminated
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Radafaxine ER with Placebo (2 arms). Primary endpoint: Change from randomisation in Montgomery-Asberg Depression Rating Scale total score at Week 8. Started Jul 2005; status: terminated.
02
Drugs
radafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2005-002261-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002261-37.